YOUR FRIENDS' ACTIVITY

    Biotech News Headlines

    • Bluebird Bio shares rocket higher in trading debut Associated Press - 2 hrs 33 mins ago

      Shares of gene therapy developer Bluebird Bio Inc. surged in their trading debut. Its shares climbed $9.91, or 58.3 percent, to close at $26.91 Wednesday after trading … More »Bluebird Bio shares rocket higher in trading debut

      Shares of gene therapy developer Bluebird Bio Inc. surged in their trading debut. Its shares climbed $9.91, or 58.3 percent, to close at $26.91 Wednesday after trading as high as $27 earlier in the session. ...

    • This combination of undated photos provided by The World Food Prize Foundation shows, from left: Robert T. Fraley and Mary-Dell Chilton of the United States, and Marc Van Montagu of Belgium who were named Wednesday, June 19, 2013, as winners of the 2013 World Food Prize during a ceremony in Washington. The private nonprofit foundation, which is in part funded by biotechnology companies, took the bold step Wednesday of awarding this year's prize to three pioneers of plant biotechnology whose work brought the world genetically modified crops. (AP Photo/The World Food Prize Foundation)
      World Food Prize goes to 3 biotech scientists DAVID PITT - AP - 7 hrs ago

      DES MOINES, Iowa (AP) — The World Food Prize Foundation on Wednesday took the bold step of awarding this year's prize to three pioneers of plant biotechnology whose work … More »World Food Prize goes to 3 biotech scientists

      This combination of undated photos provided by The World Food Prize Foundation shows, from left: Robert T. Fraley and Mary-Dell Chilton of the United States, and Marc Van Montagu of Belgium who were named Wednesday, June 19, 2013, as winners of the 2013 World Food Prize during a ceremony in Washington. The private nonprofit foundation, which is in part funded by biotechnology companies, took the bold step Wednesday of awarding this year's prize to three pioneers of plant biotechnology whose work brought the world genetically modified crops. (AP Photo/The World Food Prize Foundation)

      DES MOINES, Iowa (AP) — The World Food Prize Foundation on Wednesday took the bold step of awarding this year's prize to three pioneers of plant biotechnology whose work brought the world genetically modified crops.

    • FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman’s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)
      Court ruling may open up breast cancer gene tests MARILYNN MARCHIONE - AP - Thu, Jun 13, 2013

      A ruling by the Supreme Court that human genes can't be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the … More »Court ruling may open up breast cancer gene tests

      FILE - A technician loads patient samples into a machine for testing at Myriad Genetics Friday, May 31, 2002, in Salt Lake City. DNA samples are moved from one tray to another by the eight-needle apparatus at left. The Supreme Court ruled Thursday, June 13, 2013 that Myriad Genetics Inc. cannot patent the BRCA genes, which are tested to check a woman’s risk for breast and ovarian cancer. Mutations in these genes are what led Angelina Jolie to have both her breasts removed because she had such a high cancer risk. Some experts think the court ruling may lead to lower cost testing because there could be more competition. (AP Photo/Douglas C. Pizac)

      A ruling by the Supreme Court that human genes can't be patented is expected to increase access and drop the cost for tests for gene mutations that greatly raise the risk of developing breast or ovarian cancer.

    • As top court invalidates some gene patents, biotech has moved on Sharon Begley - Reuters - Thu, Jun 13, 2013

      By Sharon Begley NEW YORK (Reuters) - The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has been changed in the laboratory … More »As top court invalidates some gene patents, biotech has moved on

      By Sharon Begley NEW YORK (Reuters) - The U.S. Supreme Court decision on Thursday to uphold patent protections for genetic material that has been changed in the laboratory but invalidate patents for purely natural DNA may seem like a partial setback for the biotech industry, but experts said it isn't: the industry has already …

    • News Summary: Myriad stock volatile on gene ruling The Associated Press - AP - Thu, Jun 13, 2013

      ROLLERCOASTER REACTION: Diagnostic test maker Myriad Genetics saw its shares jump 10 percent, then plunge. The volatility was triggered by the Supreme Court's mixed ruling … More »News Summary: Myriad stock volatile on gene ruling

      ROLLERCOASTER REACTION: Diagnostic test maker Myriad Genetics saw its shares jump 10 percent, then plunge. The volatility was triggered by the Supreme Court's mixed ruling on the validity of patents for ...

    • High court ruling on gene patents lifts Myriad Linda a. Johnson, AP Business Writer - AP - Thu, Jun 13, 2013

      Shares of diagnostic test maker Myriad Genetics Inc. surged Thursday after the Supreme Court handed the company a partial victory in a battle over validity of Myriad … More »High court ruling on gene patents lifts Myriad

      Shares of diagnostic test maker Myriad Genetics Inc. surged Thursday after the Supreme Court handed the company a partial victory in a battle over validity of Myriad patents underlying its lucrative test ...

    • Supreme Court rules that human genes cannot be patented Warren Richey - Christian Science Monitor - Thu, Jun 13, 2013

      The US Supreme Court ruled on Thursday that human genes and the information they contain cannot be patented by medical researchers, a holding that is expected to make … More »Supreme Court rules that human genes cannot be patented

      The US Supreme Court ruled on Thursday that human genes and the information they contain cannot be patented by medical researchers, a holding that is expected to make it easier to engage in genetic research and cheaper for medical patients to obtain genetic testing.

    • An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul
      Analysis: Biotech wheat furor shows GM food safety debate far from settled Carey Gillam - Reuters - Mon, Jun 10, 2013

      By Carey Gillam (Reuters) - The refusal of some foreign buyers to purchase U.S. wheat after an unapproved genetically modified strain was discovered growing in a farm … More »Analysis: Biotech wheat furor shows GM food safety debate far from settled

      An examiner demonstrates analyzing a genetically modified wheat sample, at the Ministry of Food and Drug Safety in Seoul

      By Carey Gillam (Reuters) - The refusal of some foreign buyers to purchase U.S. wheat after an unapproved genetically modified strain was discovered growing in a farm field in Oregon is the latest demonstration that the issue of biotech food safety is far from settled. Japan and South Korea canceled purchases of U.S. wheat …

    • In this May 31, 2013, photo, breast cancer survivor Alicia Cook holds a letter from the University of Chicago informing her that test results showed she had the BRCA genetic defect linked to breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)
      Advice for black women on breast cancer gene risk MARILYNN MARCHIONE - AP - Mon, Jun 3, 2013

      CHICAGO (AP) — New research suggests that bad genes may be responsible for more breast cancer cases in black women than has been previously known. About 1 in 5 African-American … More »Advice for black women on breast cancer gene risk

      In this May 31, 2013, photo, breast cancer survivor Alicia Cook holds a letter from the University of Chicago informing her that test results showed she had the BRCA genetic defect linked to breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)

      CHICAGO (AP) — New research suggests that bad genes may be responsible for more breast cancer cases in black women than has been previously known. About 1 in 5 African-American women with the disease have an inherited mutation that drastically raises their risk for breast and ovarian cancer, according to a study released …

    • In this May 31, 2013 photo, breast cancer survivor Alicia Cook holds photos of family members who have also been afflicted by breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)
      Gene flaws common in blacks with breast cancer MARILYNN MARCHIONE - AP - Mon, Jun 3, 2013

      CHICAGO (AP) — Gene flaws that raise the risk of breast cancer are surprisingly common in black women with the disease, according to the first comprehensive testing in … More »Gene flaws common in blacks with breast cancer

      In this May 31, 2013 photo, breast cancer survivor Alicia Cook holds photos of family members who have also been afflicted by breast cancer, outside her home in Chicago. New research shows genetic breast cancer is more common in black women than previously thought. (AP Photo/M. Spencer Green)

      CHICAGO (AP) — Gene flaws that raise the risk of breast cancer are surprisingly common in black women with the disease, according to the first comprehensive testing in this racial group. The study found that one-fifth of these women have BRCA mutations, a problem usually associated with women of Eastern European Jewish …

    • Pluristem slumps as FDA suspends stem cell study AP - Tue, Jun 4, 2013

      Pluristem Therapeutics Inc. said Tuesday the Food and Drug Administration suspended a clinical trial of one of its stem cell therapies, sending the company's shares lower. … More »Pluristem slumps as FDA suspends stem cell study

      Pluristem Therapeutics Inc. said Tuesday the Food and Drug Administration suspended a clinical trial of one of its stem cell therapies, sending the company's shares lower. Pluristem said one patient in ...

    • Study finds strong genetic links for blacks with breast cancer Julie Steenhuysen - Reuters - Mon, Jun 3, 2013

      By Julie Steenhuysen CHICAGO (Reuters) - Researchers have been working for years to determine whether genetic glitches are driving high rates of especially deadly breast … More »Study finds strong genetic links for blacks with breast cancer

      By Julie Steenhuysen CHICAGO (Reuters) - Researchers have been working for years to determine whether genetic glitches are driving high rates of especially deadly breast cancer in black women in the United States. Now, the most comprehensive genetic study yet found that one in five black women already diagnosed with breast …

    • Sen. Wyden warns gene-altered wheat could become trade problem Reuters - Fri, May 31, 2013

      WASHINGTON (Reuters) - The U.S. Agriculture Department must work with other agencies to ensure that the discovery of unapproved genetically engineered wheat in Oregon … More »Sen. Wyden warns gene-altered wheat could become trade problem

      WASHINGTON (Reuters) - The U.S. Agriculture Department must work with other agencies to ensure that the discovery of unapproved genetically engineered wheat in Oregon does not become an unfair barrier to trade, one of the state's U.S. Senators said on Friday. "The discovery of non-harvested, GE (genetically engineered) …

    • Analysis: Biotech's bull run starts to look frothy Deena Beasley - Reuters - Tue, May 28, 2013

      By Deena Beasley (Reuters) - Biotech stocks are so hot that even some of the bulls are starting to find themselves on edge. An index of biotech drugmakers' shares has … More »Analysis: Biotech's bull run starts to look frothy

      By Deena Beasley (Reuters) - Biotech stocks are so hot that even some of the bulls are starting to find themselves on edge. An index of biotech drugmakers' shares has climbed nearly 50 percent in the past 12 months to all-time highs as the industry starts to launch drugs developed by identifying genes associated with disease …

    • The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva
      Swiss billionaires buy Merck Serono HQ for biotech campus Caroline Copley - Reuters - Wed, May 22, 2013

      By Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish … More »Swiss billionaires buy Merck Serono HQ for biotech campus

      The new logo of bio pharmaceutical company Merck Serono SA is pictured outside the new headquarters in Geneva

      By Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus. After selling the family business to German drugmaker Merck KGaA for $13.3 billion in 2006, the Harvard Business School graduate …

    • A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL's School of Pharmacy in London
      UK tries out new model for gene testing in cancer patients Kate Kelland - Reuters - Mon, May 20, 2013

      By Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to have access to the kind of genetic … More »UK tries out new model for gene testing in cancer patients

      A tray containing cancer cells sits on an optical microscope in the Nanomedicine Lab at UCL's School of Pharmacy in London

      By Kate Kelland LONDON (Reuters) - Britain launched a research program on Monday that should eventually allow all cancer patients to have access to the kind of genetic analysis that led Hollywood star Angelina Jolie to decide to undergo a double mastectomy. The project, involving the Institute of Cancer Research (ICR) in …

    • Affymetrix CFO Barabe to retire in June AP - Mon, May 20, 2013

      Affymetrix Chief Financial Officer Tim Barabe is planning to retire from his post next month. The genetic testing instrument business said Monday that it is promoting … More »Affymetrix CFO Barabe to retire in June

      Affymetrix Chief Financial Officer Tim Barabe is planning to retire from his post next month. The genetic testing instrument business said Monday that it is promoting Gavin Wood to the position. Barabe's ...

    • This undated image made available by the Oregon Health & Science University in May 2013 shows developing cloned human embryos. Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such illnesses as Parkinson's disease and diabetes. In the Wednesday, May 15, 2013 edition of the journal Cell, scientists at the Oregon Health & Science University report harvesting stem cells from six embryos. Shoukhrat Mitalipov, who led the research, said the success came not from a single technical innovation, but from revising a series of steps in the process. (AP Photo/Oregon Health & Science University)
      Stem cells recovered from cloned human embryos MALCOLM RITTER - AP - Wed, May 15, 2013

      NEW YORK (AP) — Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such illnesses as Parkinson's … More »Stem cells recovered from cloned human embryos

      This undated image made available by the Oregon Health & Science University in May 2013 shows developing cloned human embryos. Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such illnesses as Parkinson's disease and diabetes. In the Wednesday, May 15, 2013 edition of the journal Cell, scientists at the Oregon Health & Science University report harvesting stem cells from six embryos. Shoukhrat Mitalipov, who led the research, said the success came not from a single technical innovation, but from revising a series of steps in the process. (AP Photo/Oregon Health & Science University)

      NEW YORK (AP) — Scientists have finally recovered stem cells from cloned human embryos, a longstanding goal that could lead to new treatments for such illnesses as Parkinson's disease and diabetes.

    • This Friday, May 10, 2013 photo shows a genetically engineered potato poking through the soil of a planting pot inside J.R. Simplot's lab in southwestern Idaho. Simplot is seeking U.S. regulatory approval to market the potatoes _ which resist browning and are designed to produce lower levels of potentially cancer-causing acrylamide when fried _ to growers and, eventually, consumers. (AP Photo/John Miller)
      Idaho spud giant bets on biotech potatoes JOHN MILLER - AP - Tue, May 14, 2013

      BOISE, Idaho (AP) — A dozen years after a customer revolt forced Monsanto to ditch its genetically engineered potato, an Idaho company aims to resurrect high-tech sp … More »Idaho spud giant bets on biotech potatoes

      This Friday, May 10, 2013 photo shows a genetically engineered potato poking through the soil of a planting pot inside J.R. Simplot's lab in southwestern Idaho. Simplot is seeking U.S. regulatory approval to market the potatoes _ which resist browning and are designed to produce lower levels of potentially cancer-causing acrylamide when fried _ to growers and, eventually, consumers. (AP Photo/John Miller)

      BOISE, Idaho (AP) — A dozen years after a customer revolt forced Monsanto to ditch its genetically engineered potato, an Idaho company aims to resurrect high-tech spuds.

    • Handout photo showing the extraction of the nucleus from an egg cell
      Scientists create human stem cells through cloning Sharon Begley - Reuters - Wed, May 15, 2013

      By Sharon Begley NEW YORK (Reuters) - After more than 15 years of failures by scientists around the world and one outright fraud, biologists have finally created human … More »Scientists create human stem cells through cloning

      Handout photo showing the extraction of the nucleus from an egg cell

      By Sharon Begley NEW YORK (Reuters) - After more than 15 years of failures by scientists around the world and one outright fraud, biologists have finally created human stem cells by the same technique that produced Dolly the cloned sheep in 1996: They transplanted genetic material from an adult cell into an egg whose own …

    • FDA approves genetic test for lung cancer drug AP - Tue, May 14, 2013

      The Food and Drug Administration on Tuesday approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by the company's … More »FDA approves genetic test for lung cancer drug

      The Food and Drug Administration on Tuesday approved a genetic test from Roche to help doctors identify patients who can benefit from a lung cancer drug made by the company's Genentech unit. The diagnostic ...

    • Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz
      FDA approves Roche diagnostic for gene mutation in lung cancer Reuters - Tue, May 14, 2013

      (Reuters) - U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 percent of non-small cell lung cancers, … More »FDA approves Roche diagnostic for gene mutation in lung cancer

      Logo of Swiss pharmaceutical company Roche is pictured in Rotkreuz

      (Reuters) - U.S. health regulators on Tuesday approved a test developed by Roche for a specific gene mutation present in about 10 percent of non-small cell lung cancers, and said the company's drug Tarceva could be used as an initial treatment in patients with the mutation whose cancer has spread beyond the lungs. This …

    • Prostate cancer patient Dean Smith, left, a retired marketing executive, meets with Dr. Peter Carroll, right, at the UCSF Medical Center in San Francisco on Thursday, May 2, 2013. Carroll, chairman of urology at the University of California, San Francisco says a study he led on a new prostate cancer test - the Oncotype DX Genomic Prostate Score - suggested it could triple the number of men known to be at such low risk for aggressive disease that monitoring is a clearly safe option. Conversely, the test also suggested that some tumors were more aggressive than doctors had believed. (AP Photo/Eric Risberg)
      Gene test may help guide prostate cancer treatment MARILYNN MARCHIONE - AP - Wed, May 8, 2013

      A new genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away … More »Gene test may help guide prostate cancer treatment

      Prostate cancer patient Dean Smith, left, a retired marketing executive, meets with Dr. Peter Carroll, right, at the UCSF Medical Center in San Francisco on Thursday, May 2, 2013. Carroll, chairman of urology at the University of California, San Francisco says a study he led on a new prostate cancer test - the Oncotype DX Genomic Prostate Score - suggested it could triple the number of men known to be at such low risk for aggressive disease that monitoring is a clearly safe option. Conversely, the test also suggested that some tumors were more aggressive than doctors had believed. (AP Photo/Eric Risberg)

      A new genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it.

    • News Summary: Gene test may help cancer treatment The Associated Press - AP - Wed, May 8, 2013

      BREAKTHROUGH: A new genetic test to gauge the aggressiveness of prostate cancer may help men decide whether they need to treat their cancer right away or can safely monitor … More »News Summary: Gene test may help cancer treatment

      BREAKTHROUGH: A new genetic test to gauge the aggressiveness of prostate cancer may help men decide whether they need to treat their cancer right away or can safely monitor it. PROVIDING ANSWERS: Doctors ...

    • FILE - In this Feb. 4, 2006, file photo, IOC medical commission chairman Arne Ljungqvist responds to a question during a press conference on doping test on Austrian athletes, in Turin, Italy. Olympic officials and scientific experts will meet in in Beijing, China on June 5-6, 2013, to review the progress in developing a test for gene doping, the potential future of cheating in sports. (AP Photo/Kevork Djansezian, File)
      WADA to hold meeting in China on gene doping STEPHEN WILSON - AP - Fri, May 3, 2013

      LONDON (AP) — Olympic officials and scientific experts will meet in China next month to review the progress in developing a test for gene doping, the potential future … More »WADA to hold meeting in China on gene doping

      FILE - In this Feb. 4, 2006, file photo, IOC medical commission chairman Arne Ljungqvist responds to a question during a press conference on doping test on Austrian athletes, in Turin, Italy. Olympic officials and scientific experts will meet in in Beijing, China on June 5-6, 2013, to review the progress in developing a test for gene doping, the potential future of cheating in sports. (AP Photo/Kevork Djansezian, File)

      LONDON (AP) — Olympic officials and scientific experts will meet in China next month to review the progress in developing a test for gene doping, the potential future of cheating in sports.

     

    Follow Yahoo! News